Revolutionizing Herniated Disc Surgery | Barricaid
WEBWe work to create a world where lumbar herniation doesn’t define lives. For two decades, we worked with world-renowned surgeons, scientists, clinical investigators, and medical advisors to develop the Barricaid solution for patients at high risk for reherniation.
Management - Barricaid
WEBIntrinsic Therapeutics has been recognized as a Top 20 MedTech company to watch. Barricaid Management is detailed here in all key areas of operations.
Intrinsic Therapeutics Announces Results from Post Market Study ...
WEBBOSTON, June 28, 2023 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy, today has announced...
Intrinsic Therapeutics, Inc - LinkedIn
WEBIntrinsic Therapeutics, Inc | 3,792 followers on LinkedIn. Manufacturer of Barricaid® Designed to prevent reherniation. | Adjacent to a lumbar discectomy, the Barricaid® device is designed to...
Five Year Follow-Up of Level-1 Spine Study Confirms Long-Term …
WEBJan 25, 2022 · Intrinsic Therapeutics designed Barricaid to prevent reherniation and reoperation following lumbar discectomy surgery.
Surgeons and Spine Societies Increase Patient Access to …
WEBJun 2, 2020 · Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve efficacy in patients who are at a disproportionately high risk of requiring...
Intrinsic rounds up $49M for implant to improve spinal surgery
WEBMay 10, 2017 · Intrinsic Therapeutics raised $28 million in equity and $21 million in debt for its implant that addresses challenges in spinal surgery to remove a herniated disc. New Enterprise Associates and...
Intrinsic Therapeutics, Inc. Announces Positive Coverage Policy …
WEBJun 21, 2023 · Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy, announced today that Cigna Healthcare has issued a positive...
About us - Barricaid
WEBFor two decades, Intrinsic Therapeutics has worked with world-renowned surgeons, scientists, clinical investigators, and medical advisors to develop the Barricaid solution for patients at high risk of recurrence following discectomy.
Barricaid - Crunchbase Company Profile & Funding
WEBLegal Name Intrinsic Therapeutics, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number (781)932-0222. Barricaid develops a bone-anchored implant that reduces the incidence of reherniation and reoperation in patients with large annular defects.